Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Emilio Márquez-Contreras, Nieves Martell-Claros, Sara Márquez-Rivero, Enrique Hermida-Campa, Carmen Gracia-Diez, Eugenio Sanchez-López & Vicente Gil-Guillén. (2018) Strategies for improving dabigatran adherence for stroke prevention in patients with non-valvular atrial fibrillation: education and drug intake reminders (FACILITA study). Current Medical Research and Opinion 34:7, pages 1301-1308.
Read now
Read now
Matthias Hammwöhner & Andreas Goette. (2017) The safety of edoxaban for treating atrial fibrillation. Expert Opinion on Drug Safety 16:11, pages 1295-1303.
Read now
Read now
José Miguel Rivera-Caravaca, María Asunción Esteve-Pastor, Vanessa Roldán, Francisco Marín & Gregory Y.H. Lip. (2017) Non-vitamin K antagonist oral anticoagulants: impact of non-adherence and discontinuation. Expert Opinion on Drug Safety 16:9, pages 1051-1062.
Read now
Read now
Walter Ageno, Jan Beyer-Westendorf & Andrea Rubboli. (2017) Once- versus twice-daily direct oral anticoagulants in non-valvular atrial fibrillation. Expert Opinion on Pharmacotherapy 18:13, pages 1325-1332.
Read now
Read now
Emilio Márquez-Contreras, Nieves Martell-Carlos, Vincente Gil-Guillén, Mariano De La Figuera-Von Wichmann, Eugenio Sanchez-López, Sara Márquez-Rivero, Ines Gil-Gil & Enrique Hermida-Campa. (2016) Therapeutic compliance with rivaroxaban in preventing stroke in patients with non-valvular atrial fibrillation: CUMRIVAFA study. Current Medical Research and Opinion 32:12, pages 2013-2020.
Read now
Read now
Articles from other publishers (4)
Hyeongsoo Kim, Young Soo Lee, Tae-Hoon Kim, Myung-Jin Cha, Jung Myung Lee, Junbeom Park, Jin-Kyu Park, Ki-Woon Kang, Jaemin Shim, Jae-Sun Uhm, Hyung Wook Park, Eue-Keun Choi, Jin-Bae Kim, Changsoo Kim, Jun Kim & Boyoung Joung. (2020) A prospective survey of the persistence of warfarin or NOAC in nonvalvular atrial fibrillation: a COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF). The Korean Journal of Internal Medicine 35:1, pages 99-108.
Crossref
Crossref
Shuk-Li Collings, Cinira Lefèvre, Michelle E. Johnson, David Evans, Guido Hack, Gillian Stynes & Andrew Maguire. (2017) Oral anticoagulant persistence in patients with non-valvular atrial fibrillation: A cohort study using primary care data in Germany. PLOS ONE 12:10, pages e0185642.
Crossref
Crossref
Andreas Goette & Matthias Hammwöhner. (2016) How important it is for therapy adherence to be once a day?. European Heart Journal Supplements 18:suppl I, pages I7-I12.
Crossref
Crossref
John K. Abdou, Vivian Auyeung, Jignesh P. Patel & Roopen Arya. (2016) Adherence to long-term anticoagulation treatment, what is known and what the future might hold. British Journal of Haematology 174:1, pages 30-42.
Crossref
Crossref